308 related articles for article (PubMed ID: 18198255)
1. Pulmonary manifestations in patients with POEMS syndrome: a retrospective review of 137 patients.
Allam JS; Kennedy CC; Aksamit TR; Dispenzieri A
Chest; 2008 Apr; 133(4):969-74. PubMed ID: 18198255
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary manifestations of POEM syndrome: a retrospective analysis of 282 cases.
Huang Y; Luo Y; Hou H; Gao J
BMC Pulm Med; 2023 Nov; 23(1):465. PubMed ID: 37993859
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary hypertension in POEMS syndrome: a new feature mediated by cytokines.
Lesprit P; Godeau B; Authier FJ; Soubrier M; Zuber M; Larroche C; Viard JP; Wechsler B; Gherardi R
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):907-11. PubMed ID: 9517610
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary morbidity improves after autologous stem cell transplantation in POEMS syndrome.
Chandrashekaran S; Dispenzieri A; Cha SS; Kennedy CC
Respir Med; 2015 Jan; 109(1):122-30. PubMed ID: 25433952
[TBL] [Abstract][Full Text] [Related]
5. POEMS syndrome-related pulmonary hypertension is steroid-responsive.
Jouve P; Humbert M; Chauveheid MP; Jaïs X; Papo T
Respir Med; 2007 Feb; 101(2):353-5. PubMed ID: 16774822
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary hypertension in POEMS syndrome.
Li J; Tian Z; Zheng HY; Zhang W; Duan MH; Liu YT; Cao XX; Zhou DB
Haematologica; 2013 Mar; 98(3):393-8. PubMed ID: 22983590
[TBL] [Abstract][Full Text] [Related]
7. POEMS syndrome: definitions and long-term outcome.
Dispenzieri A; Kyle RA; Lacy MQ; Rajkumar SV; Therneau TM; Larson DR; Greipp PR; Witzig TE; Basu R; Suarez GA; Fonseca R; Lust JA; Gertz MA
Blood; 2003 Apr; 101(7):2496-506. PubMed ID: 12456500
[TBL] [Abstract][Full Text] [Related]
8. Reversible pulmonary hypertension in POEMS syndrome--another etiology of triggered pulmonary vasculopathy?
Paciocco G; Bossone E; Erba H; Rubenfire M
Can J Cardiol; 2000 Aug; 16(8):1007-12. PubMed ID: 10978936
[TBL] [Abstract][Full Text] [Related]
9. Incidence and risk factors of pleural effusions in patients with POEMS syndrome.
Cui RT; Yu SY; Huang XS; Zhang JT; Tian CL; Dou LP; Pu CQ
Hematol Oncol; 2015 Jun; 33(2):80-4. PubMed ID: 24519469
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and long-term outcome of patients with POEMS syndrome in China.
Li J; Zhou DB; Huang Z; Jiao L; Duan MH; Zhang W; Zhao YQ; Shen T
Ann Hematol; 2011 Jul; 90(7):819-26. PubMed ID: 21221584
[TBL] [Abstract][Full Text] [Related]
11. Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome.
Miralles GD; O'Fallon JR; Talley NJ
N Engl J Med; 1992 Dec; 327(27):1919-23. PubMed ID: 1333569
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological profile of polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes (POEMS) syndrome.
Kulkarni GB; Mahadevan A; Taly AB; Yasha TC; Seshagiri KS; Nalini A; Satishchandra P; Veerendrakumar M; Shankar SK
J Clin Neurosci; 2011 Mar; 18(3):356-60. PubMed ID: 21256753
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary hypertension associated with POEMS syndrome.
Ribadeau-Dumas S; Tillie-Leblond I; Rose C; Saulnier F; Wemeau JL; Hatron PY; Wallaert B
Eur Respir J; 1996 Aug; 9(8):1760-2. PubMed ID: 8866608
[TBL] [Abstract][Full Text] [Related]
14. Thrombocytosis distinguishes POEMS syndrome from chronic inflammatory demyelinating polyneuropathy.
Naddaf E; Dispenzieri A; Mandrekar J; Mauermann ML
Muscle Nerve; 2015 Oct; 52(4):658-9. PubMed ID: 26179010
[TBL] [Abstract][Full Text] [Related]
15. Prognostic study for overall survival in patients with newly diagnosed POEMS syndrome.
Wang C; Huang XF; Cai QQ; Cao XX; Duan MH; Cai H; Zhou DB; Li J
Leukemia; 2017 Jan; 31(1):100-106. PubMed ID: 27338259
[TBL] [Abstract][Full Text] [Related]
16. Skin manifestations and vascular endothelial growth factor levels in POEMS syndrome: impact of autologous hematopoietic stem cell transplantation.
Barete S; Mouawad R; Choquet S; Viala K; Leblond V; Musset L; Amoura Z; Khayat D; Francès C
Arch Dermatol; 2010 Jun; 146(6):615-23. PubMed ID: 20566924
[TBL] [Abstract][Full Text] [Related]
17. Soluble immune mediators in POEMS syndrome with pulmonary hypertension: case report and review of the literature.
Feinberg L; Temple D; de Marchena E; Patarca R; Mitrani A
Crit Rev Oncog; 1999; 10(4):293-302. PubMed ID: 10654928
[TBL] [Abstract][Full Text] [Related]
18. Systemic corticosteroids as first-line treatment in pulmonary hypertension associated with POEMS syndrome.
Rached S; Athanazio RA; Dias SA; Jardim C; Souza R
J Bras Pneumol; 2009 Aug; 35(8):804-8. PubMed ID: 19750334
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiological features of POEMS syndrome and chronic inflammatory demyelinating polyneuropathy.
Guo X; Qin X; Zhang Y; Huang C; Yu G
J Clin Neurosci; 2014 Apr; 21(4):587-90. PubMed ID: 24268501
[TBL] [Abstract][Full Text] [Related]
20. Successful weaning after plasma exchange for polyneuropathy related to POEMS syndrome.
Wu SG; Kuo PH; Yang PC
J Clin Apher; 2009; 24(4):170-2. PubMed ID: 19551807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
